Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) reported a 34.89% year-on-year (YoY) increase in net profit after tax to EGP 527.67 million in fiscal year (FY) 2025/2026, compared with EGP 391.17 million a year earlier, according to financial statements filed to the Egyptian Exchange (EGX) on August 9.
The company’s sales rose 15.47% to approximately EGP 3.19 billion in the previous FY ended June 2026, up from EGP 2.76 billion in the previous year